| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.953 | 0.001 | 0.953 | Neurokinin 1 antagonist | 0.852 0.002 CID_154699761 | ||
| 0.942 | 0.002 | 0.942 | Neurokinin antagonist | 0.836 0.002 CID_154699761 | ||
| 0.888 | 0.005 | 0.888 | Analgesic | 0.854 0.005 CID_154699761 | ||
| 0.882 | 0.001 | 0.882 | Substance P antagonist | 0.806 0.002 CID_154699761 | ||
| 0.7 | 0.031 | 0.7 | Antiinflammatory | 0.577 0.06 CID_154699761 | ||
| 0.664 | 0.009 | 0.664 | 5 Hydroxytryptamine release stimulant | 0.448 0.037 CID_154699761 | ||
| 0.4 | 0.081 | 0.4 | Calcium channel L-type activator | 0.352 0.116 CID_154699761 | ||
| 0.295 | 0.006 | 0.295 | Nav1.5 sodium channel blocker | 0.129 0.044 CID_154699761 | ||
| 0.249 | 0.025 | 0.249 | Antipruritic | 0.197 0.051 CID_154699761 | ||
| 0.237 | 0.018 | 0.237 | Sodium channel (voltage-gated) blocker | 0.113 0.093 CID_154699761 | ||
| 0.214 | 0.067 | 0.239 | Nitric-oxide synthase stimulant | 0.239 0.04 CID_154699761 | CID_154699761 | |
| 0.184 | 0.039 | 0.184 | Sodium channel blocker | |||
| 0.13 | 0.014 | 0.13 | Nav1.7 sodium channel blocker | |||
| 0.253 | 0.145 | 0.253 | Immunosuppressant | |||
| 0.266 | 0.162 | 0.266 | Antibacterial | 0.25 0.177 CID_154699761 | ||
| 0.141 | 0.047 | 0.141 | Beta amyloid protein antagonist | 0.117 0.07 CID_154699761 | ||
| 0.127 | 0.048 | 0.127 | EphA2 antagonist | |||
| 0.069 | 0.013 | 0.069 | Neurokinin 3 antagonist | 0.067 0.014 CID_154699761 | ||
| 0.067 | 0.017 | 0.067 | Neurokinin 2 antagonist | 0.052 0.022 CID_154699761 | ||
| 0.066 | 0.019 | 0.074 | Pregnane X receptor antagonist | 0.074 0.01 CID_154699761 | CID_154699761 | |
| 0.095 | 0.051 | 0.114 | Glutamate release inhibitor | 0.114 0.027 CID_154699761 | CID_154699761 | |
| 0.053 | 0.014 | 0.053 | Somatostatin 4 agonist | |||
| 0.094 | 0.065 | 0.094 | Interleukin 12 antagonist | |||
| 0.074 | 0.051 | 0.074 | Potassium channel (Tandem pore domain) blocker | |||
| 0.122 | 0.099 | 0.122 | Farnesoid X receptor antagonist | |||
| 0.055 | 0.033 | 0.055 | 5 Hydroxytryptamine 2 agonist | |||
| 0.052 | 0.03 | 0.064 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.064 0.024 CID_154699761 | CID_154699761 | |
| 0.04 | 0.021 | 0.04 | Antibiotic Aminoglycoside-like | 0.039 0.022 CID_154699761 | ||
| 0.118 | 0.102 | 0.118 | Cell wall synthesis inhibitor | |||
| 0.13 | 0.118 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.14 0.074 CID_154699761 | CID_154699761 | |
| 0.167 | 0.154 | 0.167 | Peptidyltransferase inhibitor | 0.165 0.157 CID_154699761 | ||
| 0.027 | 0.019 | 0.027 | Motilin receptor antagonist | |||
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.019 | 0.011 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.051 | 0.043 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.027 | 0.023 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 CID_154699761 | ||
| 0.054 | 0.052 | 0.054 | Adrenaline uptake inhibitor | |||
| 0.036 | 0.035 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.062 | 0.065 | 0.077 | Exportin-1 inhibitor | 0.077 0.03 CID_154699761 | CID_154699761 | |
| 0.166 | 0.234 | 0.192 | Caspase 3 stimulant | 0.192 0.182 CID_154699761 | CID_154699761 | |
| 0.097 | 0.172 | 0.121 | NOS3 expression enhancer | 0.121 0.113 CID_154699761 | CID_154699761 | |
| 0.056 | 0.178 | 0.084 | Lanosterol 14 alpha demethylase inhibitor | 0.084 0.083 CID_154699761 | CID_154699761 | |
| 0.019 | 0.586 | 0.134 | Thioredoxin inhibitor | 0.134 0.023 CID_154699761 | CID_154699761 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |